Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Hong Kong Stock Exchange  >  China Medical System Holdings Limited    867   KYG211081248

CHINA MEDICAL SYSTEM HOLDINGS LIMITED

(867)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
08/10/2020 08/11/2020 08/12/2020 08/13/2020 08/14/2020 Date
9.47 9.51 9.27 9.39 9.34 Last
2650000 4194057 4347924 9820931 4459246 Volume
-3.66% +0.42% -2.52% +1.29% -0.53% Change
Financials
Sales 2020 6 577 M 946 M 946 M
Net income 2020 2 523 M 363 M 363 M
Net cash position 2020 2 479 M 357 M 357 M
P/E ratio 2020 8,21x
Yield 2020 3,82%
Sales 2021 7 145 M 1 028 M 1 028 M
Net income 2021 2 553 M 367 M 367 M
Net cash position 2021 2 244 M 323 M 323 M
P/E ratio 2021 8,13x
Yield 2021 4,55%
Capitalization 20 693 M 2 977 M 2 977 M
EV / Sales 2020 2,77x
EV / Sales 2021 2,58x
Nbr of Employees 4 052
Free-Float 51,7%
More Financials
Company
China Medical System Holdings Limited is a Hong Kong-based investment holding company principally engaged in the manufacture, marketing, promotion and sales of pharmaceutical products. Its main products under direct network include Deanxit, Ursofalk, XinHuoSu, Salofalk, Bioflor and Augentropfen Stulln Mono Eye-drops, among others. Its products under the agency promotion network include ShaDuoLiKa, YiNuoShu and... 
Sector
Pharmaceuticals
Calendar
08/24Earnings Release
More about the company
Surperformance© ratings of China Medical System Holdi
Trading Rating : Investor Rating :
More Ratings
Toute l'actualité sur CHINA MEDICAL SYSTEM HOLDI
08/12CHINA MEDICAL SYSTEM HOLDINGS LIMITE : 2020 Interim Results Announcement
AQ
08/12CHINA MEDICAL SYSTEM : Interim results announcement for the six months ended 30 ..
PU
07/31CHINA MEDICAL SYSTEM : Terms of Reference of the Remuneration Committee
PU
07/31CHINA MEDICAL SYSTEM : Terms of Reference of the Nomination Committee
PU
06/08CHINA MEDICAL SYSTEM HOLDINGS LIMITE : Ex-dividend day for final dividend
FA
02/28CHINA MEDICAL SYSTEM : HY Medical AI and You'an Hospital join forces in the batt..
AQ
02/20CHINA MEDICAL SYSTEM : The Strength and Potential of China Medical System (867.H..
AQ
02/19CHINA MEDICAL SYSTEM : Voluntary and Business Update Announcement Donation of Cy..
PU
02/19CHINA MEDICAL SYSTEM : CytoSorbents Enters Agreement with China Medical System H..
PR
02/14CHINA MEDICAL SYSTEM : Blue Orca's Short Selling Plan Failed Because the Quality..
AQ
02/14CHINA MEDICAL SYSTEM : 867.HK) Armed against Short Selling! The Biggest CSO Took..
AQ
02/09CHINA MEDICAL SYSTEM : Voluntary announcement clarification on short seller repo..
PU
02/09CHINA MEDICAL SYSTEM : Exchange notice - resumption of trading
PU
02/07CHINA MEDICAL SYSTEM : Clarification announcement and resumption of trading
PU
01/21CHINA MEDICAL SYSTEM : Zydus and China Medical System Holdings enter into a Lice..
AQ
More news
News in other languages on CHINA MEDICAL SYSTEM HOLDI
08/12CHINA MEDICAL SYSTEM HOLDINGS LIMITE : 2020 Interim Results Announcement
08/12CHINA MEDICAL SYSTEM : Interim results announcement for the six months ended 30 ..
07/31CHINA MEDICAL SYSTEM : Terms of Reference of the Remuneration Committee
07/31CHINA MEDICAL SYSTEM : Terms of Reference of the Nomination Committee
06/22Hong Kong-Lam nommera les juges de la sécurité nationale sur recommandations
More news
Chart CHINA MEDICAL SYSTEM HOLDINGS LIMITED
Duration : Period :
China Medical System Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHINA MEDICAL SYSTEM HOLDI
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 10,72 CNY
Last Close Price 8,38 CNY
Spread / Highest target 50,1%
Spread / Average Target 28,0%
Spread / Lowest Target 10,1%
EPS Revisions
Managers
NameTitle
Kong Lam Chairman, President & Chief Executive Officer
Hong Bing Chen Chief Operating Officer, Executive Director & VP
Yan Ling Chen Chief Financial Officer, Executive Director & VP
Wai Ming Wong Chief Technical Officer
Chi Keung Wu Independent Non-Executive Director